Abstract: The invention relates to a biodegradable barrier network comprising at least two macromolecular substances, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Abstract: The invention relates to a biodegradable barrier network comprising at least two macromolecular substances, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Abstract: The invention relates to a biodegradable barrier network comprising at least two polypeptides, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Abstract: The invention relates to a biodegradable barrier network comprising at least two polypeptides, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Abstract: The invention relates to a biodegradable barrier network comprising at least two polypeptides, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.

Abstract: The invention relates to the use of at least two lactic acid bacterial strains selected from the group comprising Pediococcus pentosaceus 16:1 (LMG P-20608), Leuconostoc mesenteroides 23-77:1 (LMG P-20607), Lactobacillus paracasei subsp paracasei F-19 (LMG P-17806), and Lactobacillus plantarum 2362 (LMG P-20606) for the manufacturing of a formulation for the prevention or treatment of stress-induced inflammatory disorder.

Abstract: Probe for providing a fluid connection with the small intestine comprising a tube (10) to be inserted in the small intestine via the stomach, having proximal and distal open ends (10A, 10B) and inherent tendency of coiling over a predetermined length at the distal end, and a guide (14) displaceable in the tube from the proximal end for straightening said length in order that it shall be straightened during the actual insertion into the stomach. According to the invention the tube has at least in said predetermined portion a hairy, frosted, rough, ribbed or finned outside surface (16).

Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.

Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration. By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.

Abstract: The present invention refers to a phospholipid-based compound, that is a phospholipid to which an X-ray contrast-giving moiety has been covalently linked, liposomes comprising said compound as well as the use of said liposomes as a diagnostic or contrast agent.

Abstract: A process for isolation of a strain of Lactobacillus having the ability of being established on human intestinal mucosa in vivo and being able to remain therein after oral administration for at least 10 days after the completion of the administration.By the process the new strains L. plantarum 299 (DSM 6595) and L. casei ssp. rhamnosus 271 (DSM 6594) have been isolated, which are useful for the prophylaxis or treatment of bacterial infections, especially in the form of a fermented nutrient composition.

Abstract: A nutrient composition for administration to patients in, for example, feeding by tube, or for use as a health drink is described. The nutrient composition comprises a fermented cereal-based product, enzyme and, optionally, further nutrient components, in combination with lactobacilli. Also described is a method of preparing a nutrient composition for administration to patients, inter alia in feeding by tube, or for use as a health drink, in which method a cereal flour is mixed with water, a-amylase and, optionally, a protease, the mixture is brought to the boil under agitation, allowed to cool and mixed with B-glucanase which is allowed to act until the viscosity of the mixture has decreased to below 0.020 Pas, whereupon the mixture is fermented.

Abstract: An implantable device for occluding a body duct, especially a blood vessel. The device includes a flexible, elongate plate to be fixed around the duct, a plurality of communicating bulbs which are arranged on one side of the plate and have a variable volume, and a connection for supplying fluid to the bulbs for occluding the duct and for evacuating fluid from the bulbs to open the duct after the occlusion. The flexible plate has a perforation at one end and a locking member in the form of a thickened portion at the other end. The locking member is passed through the perforation for safely fixing the device around the body duct.To improve the occlusive function of the device, the bulbs may be made of an elastic material, the thickness of which is smallest at the tops of the bulbs.

Abstract: A space communicating with the atmosphere via a cavity and a passage is supplied with a fluid or drained by means of a tube made of a flexible elastic material and having a tendency to coil up. Upon insertion into said space, the tube is first held in a straightened-out condition by means of a guide of flexible but unelastic material which is introduced into said tube and then withdrawn therefrom to permit the tube to coil up within the cavity and to be conveyed into the space by a substance supplied to the cavity. The method can be used advantageously for supplying a drug or nutriment directly to the intestine by conducting the tube in its straightened-out condition through the nose, the throat and the gullet down into the stomach where it is allowed to coil up in order to be transported into the intestine by normal ingestion of the food.

Abstract: A rod-shaped device for internal use in connection with operations in body cavities and comprising a non-elastically deformable, flexible member surrounded by a soft liquid absorbing material which optionally is enclosed in an overwrap.